Professional Overview
Jeff Jasper is an accomplished pharmaceutical R&D executive with over 20 years of experience driving drug discovery and development initiatives. As a Senior Vice President of Research at Terns Pharmaceuticals, he leverages his deep expertise in preclinical sciences, drug discovery, and translational research to advance the company's therapeutic pipeline. Jasper also maintains roles as a Vice President, consultant, and co-founder across several other prominent life sciences organizations.
Experience Summary
Current Role
As Senior Vice President of Research at Terns Pharmaceuticals, Jasper oversees all aspects of the company's research programs. He leads cross-functional teams in progressing novel drug candidates from ideation through clinical development, with a focus on hard-to-treat diseases. Under his leadership, Terns has advanced multiple first-in-class therapies into the clinic, generating significant value for shareholders.
Career Progression
Throughout his career, Jasper has held senior R&D leadership positions at several top-tier pharmaceutical and biotech firms. As Vice President of Drug Discovery at Rubedo Life Sciences, he spearheaded the development of innovative small molecule treatments. During his tenure as Executive Director of Research Science at Merck, Jasper drove the advancement of several late-stage pipeline assets, contributing to the company's commercial success. He has also served as Vice President of Preclinical Sciences at REVOLUTION Medicines and co-founded Altos Therapeutics, a boutique consulting firm supporting early-stage drug discovery projects.
Academic Background
Jasper holds a Ph.D. in Pharmaceutical Sciences from the University of California, San Francisco, where his research specialized in medicinal chemistry and computational drug design. He also earned a Bachelor of Science degree in Chemistry from the University of California, Berkeley.
Areas of Expertise
- Preclinical drug discovery and development
- Translational research and biomarker strategies
- Medicinal and computational chemistry
- Oncology, immunology, and rare disease therapeutics
- Cross-functional team leadership and scientific collaboration
Professional Impact
Throughout his career, Jasper has made significant contributions to the pharmaceutical industry. He has co-authored numerous peer-reviewed publications and holds several patents for novel drug candidates. Jasper's work has resulted in the advancement of multiple first-in-class therapies into clinical testing, addressing unmet needs for patients with hard-to-treat conditions.
Conclusion
With his exceptional track record of driving innovative R&D initiatives, Jeff Jasper is poised to continue making a lasting impact on the pharmaceutical industry. In his current role at Terns Pharmaceuticals and through his various advisory and consulting positions, Jasper remains dedicated to developing transformative therapies that improve patient outcomes.
